Psychedelic Microdosing - Just a Placebo Effect?

Authors: Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J. Nutt, Robin L. Carhart-Harris, David Erritzoe Published: March 2, 2021 What is microdosing? Psychedelic microdosing involves consuming psychedelics such as LSD or psilocybin mushrooms at a microdose, which is typically about 10% of a recreational dose. Microdosing is gaining increasing popularity, with  …

Multi Criteria Decision Analysis for Evaluating Government Policy Responses to Heroin Use

Authors: Steve Rolles, Anne Katrin Schlag, Fiona Measham, Lawrence Phillips, David Nutt, Daniel Bergsvik, Ole Rogeberg Published: February 25, 2021 This Drug Science research was published in the International Journal of Drug Policy. A further write-up was featured in the Academic Times. Globally, non-medical heroin use is generating significant public health and social harms, and  …

Medical cannabis dependence: A critical review of issues and evidence

Authors: Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt, H Valerie Curran Published: February 17, 2021 This Drug Science research was published in the Journal of Psychopharmacology. For recreational users, the estimated chances of becoming dependent on cannabis after any lifetime exposure is 8.9%, which is considerably lower than for cocaine (20.9%), alcohol  …

So near yet so far: why won’t the UK prescribe medical cannabis?

Authors: David Nutt, Steve Bazire, Lawrence D Phillips, Anne Katrin Schlag Published: September 21, 2020 This Drug Science research was published in the British Medical Journal Open, you can download the full report here. In November 2018 when the UK made cannabis-based products for medicinal use (CBPMs) legal most people assumed these would immediately be  …